title: Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.
authors.affiliation: Section of Nephrology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
authors.forename: O
authors.initials: O
authors.lastname: Alfurayh
authors.forename: M
authors.initials: M
authors.lastname: Sobh
authors.forename: M
authors.initials: M
authors.lastname: Minhas
authors.forename: K
authors.initials: K
authors.lastname: Almeshari
authors.forename: K
authors.initials: K
authors.lastname: Alshaibani
authors.forename: W
authors.initials: W
authors.lastname: Qunibi
authors.forename: H
authors.initials: H
authors.lastname: Aesha
authors.forename: S
authors.initials: S
authors.lastname: Taher
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000704:Analysis of Variance; D016572:Cyclosporine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008107:Liver Diseases / Q000150:complications*; D008111:Liver Function Tests; D008297:Male; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D000410:Alanine Transaminase